NBRV RSI Chart
Last 7 days
-12.3%
Last 30 days
-7.9%
Last 90 days
-11.3%
Trailing 12 Months
725.1%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 36.5M | 29.6M | 0 | 0 |
2022 | 34.4M | 35.3M | 35.6M | 36.9M |
2021 | 6.8M | 14.5M | 22.1M | 28.9M |
2020 | 8.6M | 8.5M | 2.9M | 5.0M |
2019 | 3.8M | 3.5M | 9.9M | 9.5M |
2018 | 11.2M | 11.0M | 10.0M | 9.7M |
2017 | 6.7M | 6.0M | 6.5M | 5.3M |
2016 | 4.6M | 5.5M | 5.1M | 6.5M |
2015 | 2.7M | 3.1M | 3.4M | 3.8M |
2014 | 0 | 0 | 0 | 2.4M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Jan 29, 2023 | schroeder theodore r | sold (taxes) | -646 | 1.5 | -431 | - |
Jan 29, 2023 | gelone steven p. | sold (taxes) | -210 | 1.5 | -140 | - |
Jan 06, 2023 | schroeder theodore r | sold (taxes) | -14.3 | 1.3 | -11.00 | chief executive officer |
Jan 06, 2023 | gelone steven p. | sold (taxes) | -6.5 | 1.3 | -5.00 | president and coo |
Dec 31, 2022 | gelone steven p. | sold (taxes) | -5.67 | 1.89 | -3.00 | president and coo |
Dec 31, 2022 | schroeder theodore r | sold (taxes) | -9.45 | 1.89 | -5.00 | chief executive officer |
Dec 06, 2022 | schroeder theodore r | sold (taxes) | -18.18 | 2.02 | -9.00 | chief executive officer |
Dec 06, 2022 | gelone steven p. | sold (taxes) | -8.08 | 2.02 | -4.00 | president and coo |
Nov 30, 2022 | schroeder theodore r | sold (taxes) | -11.25 | 2.25 | -5.00 | chief executive officer |
Nov 30, 2022 | gelone steven p. | sold (taxes) | -6.75 | 2.25 | -3.00 | president and coo |
Which funds bought or sold NBRV recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 22, 2024 | Bay Harbor Wealth Management, LLC | sold off | -100 | - | - | -% |
Unveiling Nabriva Therapeutics PLC's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Nabriva Therapeutics PLC News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | -70.4% | 2,243,000 | 7,590,000 | 10,571,000 | 9,153,000 | 9,191,000 | 8,020,000 | 9,261,000 | 8,862,000 | 8,243,000 | 2,529,000 | 2,460,000 | 1,291,000 | 487,000 | 789,000 | 333,000 | 6,920,000 | 525,000 | 1,703,000 | 797,000 | 461,000 | 847,000 |
Cost Of Revenue | 104.5% | 9,074,000 | 4,438,000 | 16,349,000 | 4,416,000 | 4,455,000 | 3,361,000 | 5,266,000 | 4,199,000 | 3,621,000 | 62,000 | - | 25,000 | - | - | - | - | - | - | - | - | - |
Costs and Expenses | -11.2% | 14,267,000 | 16,065,000 | 32,902,000 | 20,355,000 | 19,590,000 | 19,578,000 | 22,145,000 | 19,676,000 | 19,625,000 | 15,977,000 | 20,728,000 | 14,508,000 | 14,940,000 | 20,977,000 | 22,403,000 | 24,119,000 | 21,501,000 | 20,947,000 | 31,676,000 | 53,386,000 | 18,554,000 |
Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 21,501,000 | 20,947,000 | 31,676,000 | 53,386,000 | 18,554,000 |
S&GA Expenses | -54.4% | 4,107,000 | 9,002,000 | 9,610,000 | 11,907,000 | 11,047,000 | 12,700,000 | 14,488,000 | 12,256,000 | 12,854,000 | 12,047,000 | 17,522,000 | 10,997,000 | 10,741,000 | 16,025,000 | 17,146,000 | 18,503,000 | 13,427,000 | 13,409,000 | 10,188,000 | 12,582,000 | 8,837,000 |
R&D Expenses | -58.6% | 1,086,000 | 2,625,000 | 2,626,000 | 4,032,000 | 4,088,000 | 3,517,000 | 2,391,000 | 3,221,000 | 3,150,000 | 3,868,000 | 2,841,000 | 3,486,000 | 3,831,000 | 4,944,000 | 5,202,000 | 5,601,000 | 8,074,000 | 7,538,000 | 21,488,000 | 40,804,000 | 9,717,000 |
EBITDA Margin | -26.4% | -1.80 | -1.42 | -1.48 | -1.26 | -1.27 | -1.32 | -1.65 | -2.44 | -3.82 | -8.74 | -13.38 | -24.66 | - | - | - | - | - | - | - | - | - |
Interest Expenses | 100.5% | 1,000 | -194,000 | 1,257,000 | -146,000 | -198,000 | -215,000 | 1,579,000 | -221,000 | -236,000 | -221,000 | 158,000 | 256,000 | 251,000 | 1,024,000 | 877,000 | 709,000 | 904,000 | 899,000 | 114,000 | 8,000 | 7,000 |
Income Taxes | - | - | - | 268,000 | 500,000 | 400,000 | 400,000 | -59,000 | -252,000 | 606,000 | 200,000 | -37,000 | -100,000 | 100,000 | 152,000 | 21,000 | -29,000 | -45,000 | 154,000 | -259,000 | -151,000 | -48,000 |
Earnings Before Taxes | -38.6% | -12,062,000 | -8,700,000 | -22,469,000 | -10,994,000 | -10,689,000 | -11,465,000 | -13,117,000 | -10,904,000 | -11,148,000 | -13,791,000 | -17,893,000 | -13,023,000 | -15,322,000 | -23,107,000 | -23,024,000 | -17,824,000 | -21,752,000 | -20,063,000 | -31,083,000 | -52,976,000 | -17,836,000 |
EBT Margin | -26.7% | -1.83 | -1.45 | -1.51 | -1.30 | -1.31 | -1.36 | -1.69 | -2.43 | -3.85 | -8.87 | -13.79 | -25.68 | - | - | - | - | - | - | - | - | - |
Net Income | -38.6% | -12,062,000 | -8,700,000 | -22,778,000 | -11,514,000 | -11,074,000 | -11,819,000 | -13,063,000 | -10,652,000 | -11,754,000 | -13,981,000 | -17,833,000 | -12,951,000 | -15,441,000 | -23,259,000 | -23,045,000 | -17,795,000 | -21,707,000 | -20,217,000 | -30,824,000 | -52,825,000 | -17,788,000 |
Net Income Margin | -25.8% | -1.86 | -1.48 | -1.55 | -1.33 | -1.32 | -1.38 | -1.71 | -2.45 | -3.89 | -8.90 | -13.82 | -25.76 | - | - | - | - | - | - | - | - | - |
Free Cashflow | 109.1% | 511,000 | -5,618,000 | -1,625,000 | -6,177,000 | -13,039,000 | -15,870,000 | -6,118,000 | -13,239,000 | -18,574,000 | -21,626,000 | -13,364,000 | -12,595,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | -56.5% | 11.00 | 24.00 | 32.00 | 48.00 | 55.00 | 66.00 | 81.00 | 89.00 | 95.00 | 79.00 | 58.00 | 57.00 | 65.00 | 41.00 | 94.00 | 90.00 | 84.00 | 104 | 110 | 112 | 87.00 |
Current Assets | -58.0% | 10.00 | 24.00 | 31.00 | 48.00 | 54.00 | 65.00 | 80.00 | 88.00 | 95.00 | 78.00 | 57.00 | 54.00 | 62.00 | 38.00 | 91.00 | 86.00 | 80.00 | 100 | 109 | 111 | 85.00 |
Cash Equivalents | 21.4% | 2.00 | 2.00 | 12.00 | 15.00 | 20.00 | 34.00 | 48.00 | 52.00 | 61.00 | 55.00 | 42.00 | 41.00 | 50.00 | 27.00 | 86.00 | 78.00 | 74.00 | 91.00 | 102 | 100 | 75.00 |
Inventory | -100.0% | - | 9.00 | 10.00 | 17.00 | 16.00 | 16.00 | 15.00 | 16.00 | 10.00 | 9.00 | 6.00 | 6.00 | 5.00 | 4.00 | 1.00 | 0.00 | - | - | - | - | - |
Net PPE | -6.5% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 | 3.00 | 3.00 | 1.00 | 1.00 | 1.00 |
Liabilities | -6.3% | 27.00 | 29.00 | 28.00 | 23.00 | 20.00 | 21.00 | 28.00 | 26.00 | 26.00 | 24.00 | 25.00 | 21.00 | 21.00 | 21.00 | 53.00 | 51.00 | 40.00 | 44.00 | 42.00 | 16.00 | 12.00 |
Current Liabilities | -6.4% | 26.00 | 28.00 | 28.00 | 22.00 | 19.00 | 16.00 | 22.00 | 20.00 | 19.00 | 18.00 | 19.00 | 11.00 | 11.00 | 12.00 | 17.00 | 15.00 | 14.00 | 18.00 | 18.00 | 15.00 | 11.00 |
Long Term Debt | -0.3% | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 4.00 | 4.00 | 5.00 | 6.00 | 5.00 | 6.00 | 8.00 | 7.00 | 7.00 | 35.00 | 34.00 | 24.00 | 24.00 | 24.00 | 1.00 | 1.00 |
LT Debt, Current | -0.5% | 0.00 | 0.00 | 5.00 | 6.00 | 7.00 | 4.00 | 4.00 | 3.00 | 2.00 | 3.00 | 2.00 | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | -0.3% | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 4.00 | 4.00 | 5.00 | 6.00 | 5.00 | 6.00 | 8.00 | 7.00 | 7.00 | 35.00 | 34.00 | 24.00 | 24.00 | 24.00 | 1.00 | 1.00 |
Shareholder's Equity | - | - | - | 3.00 | 26.00 | 35.00 | 45.00 | 53.00 | 63.00 | 69.00 | 55.00 | 33.00 | 36.00 | 44.00 | 20.00 | 41.00 | 39.00 | 43.00 | 60.00 | 69.00 | 96.00 | 75.00 |
Retained Earnings | -1.8% | -673 | -661 | -652 | -630 | -618 | -607 | -595 | -582 | -571 | -560 | -546 | -528 | -515 | -500 | -476 | -453 | -435 | -414 | -393 | -363 | -310 |
Additional Paid-In Capital | 0.0% | 657 | 657 | 656 | 656 | 653 | 651 | 649 | 645 | 641 | 615 | 579 | 563 | 558 | 519 | 518 | 492 | 479 | 474 | 462 | 459 | 385 |
Shares Outstanding | 0.9% | 3.00 | 3.00 | 3.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 | 0.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | - | 12.00 | - | - | - | 68.00 | - | - | - | 95.00 | - | - | - | 176 | - | - | - | 142 |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 109.1% | 511 | -5,618 | -1,625 | -6,177 | -13,039 | -15,870 | -6,118 | -13,239 | -18,574 | -21,626 | -13,364 | -12,595 | -17,264 | -28,108 | -15,487 | -14,735 | -21,045 | -20,625 | -22,231 | -17,132 | -17,021 |
Share Based Compensation | -90.2% | 98.00 | 999 | 135 | 498 | 334 | 1,000 | 774 | 779 | 817 | 921 | 953 | 1,163 | 1,338 | 1,765 | 1,882 | 4,138 | 1,821 | 1,907 | 1,720 | 1,423 | 767 |
Cashflow From Investing | -1566.7% | -50.00 | -3.00 | -7.00 | -104 | -116 | -36.00 | -12.00 | - | 51.00 | -120 | -17.00 | -9.00 | -228 | -20.00 | 200 | 188 | -15.00 | -42.00 | -229 | -4,092 | -123 |
Cashflow From Financing | 100.0% | - | -4,852 | -659 | 1,108 | -792 | 2,194 | 2,138 | 4,072 | 25,226 | 34,930 | 14,021 | 3,735 | 39,387 | -30,219 | 23,395 | 19,252 | 3,749 | 9,679 | 24,327 | 46,378 | 3,159 |
Consolidated Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenues: | ||||
Total revenues | $ 2,243 | $ 9,191 | $ 9,833 | $ 17,211 |
Operating expenses: | ||||
Cost of revenues | (9,074) | (4,455) | (13,512) | (7,816) |
Research and development expenses | (1,086) | (4,088) | (3,711) | (7,605) |
Selling, general and administrative expenses | (4,107) | (11,047) | (13,107) | (23,747) |
Total operating expenses | (14,267) | (19,590) | (30,330) | (39,168) |
Loss from operations | (12,024) | (10,399) | (20,497) | (21,957) |
Other (expense) income: | ||||
Other (expense) income, net | (39) | (92) | (70) | 216 |
Interest income (expense), net | 1 | (198) | (194) | (413) |
Loss before income taxes | (12,062) | (10,689) | (20,761) | (22,154) |
Income tax expense | 0 | (385) | (1) | (739) |
Net loss | $ (12,062) | $ (11,074) | $ (20,762) | $ (22,893) |
Loss per share | ||||
Basic loss ($ per share) | $ (3.73) | $ (4.38) | $ (6.43) | $ (9.38) |
Diluted loss ($ per share) | $ (3.73) | $ (4.38) | $ (6.43) | $ (9.38) |
Weighted average number of shares: | ||||
Basic (in shares) | 3,230,827 | 2,529,523 | 3,227,629 | 2,441,136 |
Diluted (in shares) | 3,230,827 | 2,529,523 | 3,227,629 | 2,441,136 |
Product revenue, net | ||||
Revenues: | ||||
Total revenues | $ 2,574 | $ 8,680 | $ 10,135 | $ 15,720 |
Collaboration revenue | ||||
Revenues: | ||||
Total revenues | 0 | 96 | 29 | 725 |
Research premium and grant revenue | ||||
Revenues: | ||||
Total revenues | $ (331) | $ 415 | $ (331) | $ 766 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 2,182 | $ 12,414 |
Restricted cash | 73 | 123 |
Accounts receivable, net and other receivables | 4,439 | 6,742 |
Inventory | 9,676 | |
Prepaid expenses | 3,258 | 2,149 |
Total current assets | 9,952 | 31,104 |
Property and equipment, net | 246 | 280 |
Intangible assets, net | 1 | 3 |
Other non-current assets | 379 | 378 |
Total assets | 10,578 | 31,765 |
Current liabilities: | ||
Current portion of long-term debt | 196 | 4,833 |
Accounts payable | 14,026 | 5,431 |
Accrued expense and other current liabilities | 11,981 | 17,341 |
Total current liabilities | 26,203 | 27,605 |
Non-current liabilities: | ||
Long-term debt | 344 | 388 |
Other non-current liabilities | 352 | 479 |
Total non-current liabilities | 696 | 867 |
Total liabilities | 26,899 | 28,472 |
Commitments and contingencies (Note 11) | ||
Stockholders' (deficit) equity: | ||
Ordinary shares, nominal value $0.01, 12,000,000 ordinary shares authorized at June 30, 2023 and December 31, 2022; 3,230,837 and 3,201,417 issued and outstanding at June 30, 2023 and December 31, 2022, respectively | 32 | 32 |
Preferred shares, nominal value $0.01, 100,000,000 shares authorized at June 30, 2023 and December 31, 2022; None issued and outstanding | ||
Additional paid in capital | 657,243 | 656,095 |
Accumulated deficit | (673,623) | (652,861) |
Accumulated other comprehensive income | 27 | 27 |
Total stockholders' (deficit) equity | (16,321) | 3,293 |
Total liabilities and stockholders' (deficit) equity | $ 10,578 | $ 31,765 |